Literature DB >> 25555320

Breast and ovarian cancer survivors' experience of participating in a cognitive-existential group intervention addressing fear of cancer recurrence.

Christine Maheu1, Sophie Lebel2, Christina Tomei2, Mina Singh3, Mary Jane Esplen4.   

Abstract

PURPOSE: Currently, very few clinical approaches are offered to cancer survivors dealing with fear of cancer recurrence (FCR). This paper provides an overview of cancer survivors' experience and satisfaction after taking part in a six-week, cognitive-existential (CE) group intervention that aimed to address FCR.
METHOD: In this qualitative descriptive study, 12 women with breast or ovarian cancer provided in-depth interviews of their experience in taking part in the CE group intervention.
RESULTS: Analysis of their accounts revealed struggles to face their fears. Yet, by embracing their group experience, the women learned how to confront their fears and gain emotional control. The women reported that the group work was highly valuable.
CONCLUSION: From the women's analysed accounts, the authors have proposed recommendations for changes to the group work process before moving the study to a full clinical trial. The study's findings also provide valuable insights to other cancer survivor groups who may also be experiencing FCR.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast and ovarian cancer; Cognitive-existential approach; Fear of cancer recurrence; Group intervention; Participation satisfaction; Qualitative study

Mesh:

Year:  2014        PMID: 25555320     DOI: 10.1016/j.ejon.2014.12.003

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  4 in total

1.  An exploratory study of the worst-case scenario exercise as an exposure treatment for fear of cancer recurrence.

Authors:  Chelsea Moran; Christina Tomei; Monique Lefebvre; Cheryl Harris; Christine Maheu; Sophie Lebel
Journal:  Support Care Cancer       Date:  2017-02-02       Impact factor: 3.603

2.  When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence.

Authors:  Brittany Mutsaers; Georden Jones; Nicole Rutkowski; Christina Tomei; Caroline Séguin Leclair; Danielle Petricone-Westwood; Sébastien Simard; Sophie Lebel
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

3.  Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal.

Authors:  L Curran; L Sharpe; C MacCann; P Butow
Journal:  J Behav Med       Date:  2020-01-06

4.  Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.

Authors:  Christine Maheu; Sophie Lebel; Christine Courbasson; Monique Lefebvre; Mina Singh; Lori J Bernstein; Linda Muraca; Aronela Benea; Lynne Jolicoeur; Cheryl Harris; Agnihotram V Ramanakumar; Sarah Ferguson; Souraya Sidani
Journal:  BMC Cancer       Date:  2016-04-25       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.